Pyruvate and Metabolic Flexibility: Illuminating a Path Toward Selective Cancer Therapies.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 26873641)

Published in Trends Biochem Sci on February 10, 2016

Authors

Kristofor A Olson1, John C Schell1, Jared Rutter2

Author Affiliations

1: Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84112-5650, USA.
2: Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT 84112-5650, USA; Howard Hughes Medical Institute, University of Utah School of Medicine, Salt Lake City, UT 84112-5650, USA. Electronic address: rutter@biochem.utah.edu.

Articles cited by this

(truncated to the top 100)

Hallmarks of cancer: the next generation. Cell (2011) 140.01

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature (1999) 23.45

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature (2008) 18.20

HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab (2006) 13.22

Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev (1998) 12.48

A conserved family of prolyl-4-hydroxylases that modify HIF. Science (2001) 11.50

HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab (2006) 10.14

Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell (2006) 9.80

Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature (2008) 9.77

A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell (2007) 9.20

THE METABOLISM OF TUMORS IN THE BODY. J Gen Physiol (1927) 7.64

Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest (2008) 7.52

Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem (1996) 7.37

HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer (2011) 6.32

Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer (2008) 6.02

Tumor heterogeneity: causes and consequences. Biochim Biophys Acta (2009) 5.90

c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev (2004) 5.83

Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci U S A (2010) 4.97

Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene (2006) 4.05

Mechanism of activation of pyruvate dehydrogenase by dichloroacetate and other halogenated carboxylic acids. Biochem J (1974) 3.89

HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations. J Clin Invest (2013) 3.55

A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature (2013) 3.46

Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat Chem Biol (2012) 3.40

A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans. Science (2012) 3.39

The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. J Biol Chem (2006) 3.21

Identification and functional expression of the mitochondrial pyruvate carrier. Science (2012) 3.15

Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell (2011) 3.05

PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat Cell Biol (2014) 3.02

Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J Biol Chem (2000) 3.02

Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism. Mol Cell (2011) 2.61

Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells. Cell Stem Cell (2013) 2.58

Using the "reverse Warburg effect" to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers. Cell Cycle (2012) 2.55

Metabolic requirements for the maintenance of self-renewing stem cells. Nat Rev Mol Cell Biol (2014) 2.36

Metabolic pathways promoting cancer cell survival and growth. Nat Cell Biol (2015) 2.35

Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay. Cancer Res (2012) 2.20

MYC, metabolism, cell growth, and tumorigenesis. Cold Spring Harb Perspect Med (2013) 2.19

Metabolic regulation by the mitochondrial phosphatase PTPMT1 is required for hematopoietic stem cell differentiation. Cell Stem Cell (2013) 2.12

The monocarboxylate transporter family--role and regulation. IUBMB Life (2011) 2.07

An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate Synthesis. Cell (2015) 2.03

The monocarboxylate transporter family--Structure and functional characterization. IUBMB Life (2011) 1.92

SDH mutations in cancer. Biochim Biophys Acta (2011) 1.92

Targeting lactate dehydrogenase--a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells. Cell Metab (2014) 1.92

Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating Cells. Cell (2015) 1.90

Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell (2014) 1.90

Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. Am J Physiol (1970) 1.84

Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions. J Biol Chem (2001) 1.84

Acetate dependence of tumors. Cell (2014) 1.80

Cardiac metabolism in heart failure: implications beyond ATP production. Circ Res (2013) 1.72

Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport. Mol Cell (2014) 1.63

Succinate dehydrogenase - Assembly, regulation and role in human disease. Mitochondrion (2010) 1.56

Acetyl-CoA synthetase 2 promotes acetate utilization and maintains cancer cell growth under metabolic stress. Cancer Cell (2015) 1.52

myc maintains embryonic stem cell pluripotency and self-renewal. Differentiation (2010) 1.50

Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma. FEBS J (2012) 1.41

HIF-1α pathway: role, regulation and intervention for cancer therapy. Acta Pharm Sin B (2015) 1.40

Diisopropylammonium dichloroacetate (DIPA) and sodium dichloracetate (DCA): effect on glucose and fat metabolism in normal and diabetic tissue. Metabolism (1970) 1.37

A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth. Mol Cell (2014) 1.34

Lactate dehydrogenase A in cancer: a promising target for diagnosis and therapy. IUBMB Life (2013) 1.31

Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth. Semin Cancer Biol (2014) 1.31

Regulation of substrate utilization by the mitochondrial pyruvate carrier. Mol Cell (2014) 1.30

Loss of Mitochondrial Pyruvate Carrier 2 in the Liver Leads to Defects in Gluconeogenesis and Compensation via Pyruvate-Alanine Cycling. Cell Metab (2015) 1.28

Hepatic Mitochondrial Pyruvate Carrier 1 Is Required for Efficient Regulation of Gluconeogenesis and Whole-Body Glucose Homeostasis. Cell Metab (2015) 1.28

Pyruvate kinase isoform expression alters nucleotide synthesis to impact cell proliferation. Mol Cell (2014) 1.26

Hypoxic regulation of hand1 controls the fetal-neonatal switch in cardiac metabolism. PLoS Biol (2013) 1.18

Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury. Cardiovasc Res (2012) 1.18

PDK1 inhibition is a novel therapeutic target in multiple myeloma. Br J Cancer (2012) 1.16

Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progression. Br J Cancer (2010) 1.16

Improved energy homeostasis of the heart in the metabolic state of exercise. Am J Physiol Heart Circ Physiol (2000) 1.12

Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer. J Cancer Res Clin Oncol (2014) 1.05

Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial-mesenchymal transition. Proc Natl Acad Sci U S A (2014) 1.05

Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers. Oncotarget (2014) 1.03

Induction of hypoxia-inducible factor-1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: evidence against a regulatory role for Src kinase. Blood (1997) 1.02

Lactate dehydrogenase A negatively regulated by miRNAs promotes aerobic glycolysis and is increased in colorectal cancer. Oncotarget (2015) 1.01

Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast. BMC Cancer (2014) 0.97

The multifaceted regulation and functions of PKM2 in tumor progression. Biochim Biophys Acta (2014) 0.95

Failing mouse hearts utilize energy inefficiently and benefit from improved coupling of glycolysis and glucose oxidation. Cardiovasc Res (2013) 0.94

Effect of aging on muscle mitochondrial substrate utilization in humans. Proc Natl Acad Sci U S A (2015) 0.92

MCT4 defines a glycolytic subtype of pancreatic cancer with poor prognosis and unique metabolic dependencies. Cell Rep (2014) 0.92

Intratumoral heterogeneity in the self-renewal and tumorigenic differentiation of ovarian cancer. Stem Cells (2012) 0.91

Oxygen tension controls the expression of the monocarboxylate transporter MCT4 in cultured mouse cortical astrocytes via a hypoxia-inducible factor-1α-mediated transcriptional regulation. Glia (2013) 0.90

Intratumoral Heterogeneity: From Diversity Comes Resistance. Clin Cancer Res (2015) 0.90

Protein tyrosine phosphatase 1B regulates pyruvate kinase M2 tyrosine phosphorylation. J Biol Chem (2013) 0.90

Sodium dichloroacetate (DCA) reduces apoptosis in colorectal tumor hypoxia. Cancer Lett (2010) 0.90

Physical map of the D6S149-D6S193 region on chromosome 6Q27 and its involvement in benign surface epithelial ovarian tumours. Oncogene (1998) 0.89

Monocarboxylate transporter 4 facilitates cell proliferation and migration and is associated with poor prognosis in oral squamous cell carcinoma patients. PLoS One (2014) 0.88

Cancer's Fuel Choice: New Flavors for a Picky Eater. Mol Cell (2015) 0.86

Case report: Sodium dichloroacetate (DCA) inhibition of the "Warburg Effect" in a human cancer patient: complete response in non-Hodgkin's lymphoma after disease progression with rituximab-CHOP. J Bioenerg Biomembr (2012) 0.86

Differentiate or Die: 3-Bromopyruvate and Pluripotency in Mouse Embryonic Stem Cells. PLoS One (2015) 0.86

Redox and metabolic regulation of stem/progenitor cells and their niche. Antioxid Redox Signal (2014) 0.86

Inhibition of the pentose phosphate pathway by dichloroacetate unravels a missing link between aerobic glycolysis and cancer cell proliferation. Oncotarget (2016) 0.85

Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer. Cancer Lett (2015) 0.84

Prognostic significance of monocarboxylate transporter 4 expression in patients with colorectal cancer. Exp Ther Med (2011) 0.84

DCA promotes progression of neuroblastoma tumors in nude mice. Am J Cancer Res (2015) 0.82

In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compounds. Clin Pharmacol (2010) 0.82

Sirt3 binds to and deacetylates mitochondrial pyruvate carrier 1 to enhance its activity. Biochem Biophys Res Commun (2015) 0.81

Dichloroacetate affects proliferation but not survival of human colorectal cancer cells. Apoptosis (2015) 0.81

Availability of energetic substrates and exercise performance in heart failure with or without diabetes. Eur J Heart Fail (2012) 0.80

Pyruvate dehydrogenase kinase expression and metabolic changes following dichloroacetate exposure in anoxic human colorectal cancer cells. Exp Cell Res (2014) 0.80

Defective Expression of the Mitochondrial-tRNA Modifying Enzyme GTPBP3 Triggers AMPK-Mediated Adaptive Responses Involving Complex I Assembly Factors, Uncoupling Protein 2, and the Mitochondrial Pyruvate Carrier. PLoS One (2015) 0.79

Hypoxic regulation of metabolism offers new opportunities for anticancer therapy. Expert Rev Anticancer Ther (2014) 0.79

Glucose-lactate metabolic cooperation in cancer: insights from a spatial mathematical model and implications for targeted therapy. J Theor Biol (2014) 0.78